Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > As predicted. shorting away

<< Previous

Bullboard Posts

Next >>

Comment by 13X2413on May 15, 2024 2:25pm

84 Views

Post# 36041651

RE:RE:As predicted. shorting away

No offence CF. I would love to see some big players look positively at all this news. The 3 or 4 guys/gals who seem overly positive aren't enough to get this price out of the doldrums. Why isn't big money all hyped up like you and AzzNote?

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?